Insiders · Profile

Deliargyris Efthymios

Chief Medical Officer at Cytosorbents. Filing since 13 Dec 2023. CIK 0001751617

Company
Date
Role
Action
Shares
Amount
Of holding
13 Dec 2023
Chief Medical Officer
Bought
22,557
$30.00K
6.9%
1 decision on file.